Similar articles

• [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].

  Tempini S, Bellati G, Ideo G. Tempini S, et al. Minerva Dietol Gastroenterol. 1984 Jul-Sep;30(3):255-61. Minerva Dietol Gastroenterol. 1984. PMID: 6504374 Italian. No abstract available.
• [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].

  Traina M, Vizzini GB. Traina M, et al. Minerva Med. 1986 Jan 28;77(3-4):87-91. Minerva Med. 1986. PMID: 3511409 Clinical Trial. Italian.
• [Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention].

  Coltorti M, Radaeli E, Ciaccio S, Corsini R, Trebbi R. Coltorti M, et al. Clin Ter. 1976 Feb 15;76(3):215-34. Clin Ter. 1976. PMID: 963962 Italian. No abstract available.
• Atrial natriuretic peptide: renal effects in cirrhosis of the liver.

  Levy M. Levy M. Semin Nephrol. 1997 Nov;17(6):520-9. Semin Nephrol. 1997. PMID: 9353863 Review.
• [The diuretic effect of demethylchlortetracycline in non-compensated hepatic cirrhosis].

  Ronchi E, Cattani F, Croce G, Magri F, Cappellini F, Rosati R, Lucchelli PD. Ronchi E, et al. Recenti Prog Med. 1981 Apr;70(4):418-32. Recenti Prog Med. 1981. PMID: 6789413 Review. Italian. No abstract available.